237 related articles for article (PubMed ID: 23478800)
1. Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1.
Lopez-Haber C; Kazanietz MG
Mol Pharmacol; 2013 May; 83(5):1141-54. PubMed ID: 23478800
[TBL] [Abstract][Full Text] [Related]
2. Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via Hypoxia-Inducible Factor 1α.
Lopez-Haber C; Barrio-Real L; Casado-Medrano V; Kazanietz MG
Mol Cell Biol; 2016 Aug; 36(15):2011-26. PubMed ID: 27185877
[TBL] [Abstract][Full Text] [Related]
3. Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer.
Sosa MS; Lopez-Haber C; Yang C; Wang H; Lemmon MA; Busillo JM; Luo J; Benovic JL; Klein-Szanto A; Yagi H; Gutkind JS; Parsons RE; Kazanietz MG
Mol Cell; 2010 Dec; 40(6):877-92. PubMed ID: 21172654
[TBL] [Abstract][Full Text] [Related]
4. G Protein betagamma subunits stimulate p114RhoGEF, a guanine nucleotide exchange factor for RhoA and Rac1: regulation of cell shape and reactive oxygen species production.
Niu J; Profirovic J; Pan H; Vaiskunaite R; Voyno-Yasenetskaya T
Circ Res; 2003 Oct; 93(9):848-56. PubMed ID: 14512443
[TBL] [Abstract][Full Text] [Related]
5. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
[TBL] [Abstract][Full Text] [Related]
6. Integrin α6β4 cooperates with LPA signaling to stimulate Rac through AKAP-Lbc-mediated RhoA activation.
O'Connor KL; Chen M; Towers LN
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C605-14. PubMed ID: 22049212
[TBL] [Abstract][Full Text] [Related]
7. Rac signaling in breast cancer: a tale of GEFs and GAPs.
Wertheimer E; Gutierrez-Uzquiza A; Rosemblit C; Lopez-Haber C; Sosa MS; Kazanietz MG
Cell Signal; 2012 Feb; 24(2):353-362. PubMed ID: 21893191
[TBL] [Abstract][Full Text] [Related]
8. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
9. A role for Gab1/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis.
Wang D; Paria BC; Zhang Q; Karpurapu M; Li Q; Gerthoffer WT; Nakaoka Y; Rao GN
Circ Res; 2009 May; 104(9):1066-75. PubMed ID: 19359598
[TBL] [Abstract][Full Text] [Related]
10. Activation of Dbl restores migration in polyamine-depleted intestinal epithelial cells via Rho-GTPases.
Ray RM; Bavaria MN; Bhattacharya S; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G988-97. PubMed ID: 21372162
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a P-Rex1 gene signature in breast cancer cells.
Barrio-Real L; Wertheimer E; Garg R; Abba MC; Kazanietz MG
Oncotarget; 2016 Aug; 7(32):51335-51348. PubMed ID: 27351228
[TBL] [Abstract][Full Text] [Related]
12. 15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling.
Singh NK; Wang D; Kundumani-Sridharan V; Van Quyen D; Niu J; Rao GN
J Biol Chem; 2011 Jun; 286(25):22478-88. PubMed ID: 21536676
[TBL] [Abstract][Full Text] [Related]
13. Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines.
Cardama GA; Comin MJ; Hornos L; Gonzalez N; Defelipe L; Turjanski AG; Alonso DF; Gomez DE; Menna PL
Anticancer Agents Med Chem; 2014; 14(6):840-51. PubMed ID: 24066799
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase.
Aslam M; Schluter KD; Rohrbach S; Rafiq A; Nazli S; Piper HM; Noll T; Schulz R; Gündüz D
J Physiol; 2013 Jan; 591(2):461-73. PubMed ID: 23090948
[TBL] [Abstract][Full Text] [Related]
15. The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer.
Yang X; Cruz MI; Nguyen EV; Huang C; Schittenhelm RB; Luu J; Cowley KJ; Shin SY; Nguyen LK; Lim Kam Sian TCC; Clark KC; Simpson KJ; Ma X; Daly RJ
Oncogene; 2023 Mar; 42(11):833-847. PubMed ID: 36693952
[TBL] [Abstract][Full Text] [Related]
16. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
17. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
Debidda M; Wang L; Zang H; Poli V; Zheng Y
J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
[TBL] [Abstract][Full Text] [Related]
18. Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
Yang C; Liu Y; Lemmon MA; Kazanietz MG
Mol Cell Biol; 2006 Feb; 26(3):831-42. PubMed ID: 16428439
[TBL] [Abstract][Full Text] [Related]
19. RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells.
El-Sibai M; Pertz O; Pang H; Yip SC; Lorenz M; Symons M; Condeelis JS; Hahn KM; Backer JM
Exp Cell Res; 2008 Apr; 314(7):1540-52. PubMed ID: 18316075
[TBL] [Abstract][Full Text] [Related]
20. Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS.
Liang JR; Yang H
Biomed Pharmacother; 2020 May; 125():109585. PubMed ID: 32106377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
